BELITE BIO INC - AMERICAN DEPOSITARY SHARES

Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japan

12 июн 2024 02:55:28 Источник Nasdaq GlobeNewswire

Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference

14 май 2024 08:00:00 Источник Nasdaq GlobeNewswire

Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update

13 май 2024 21:50:29 Источник Nasdaq GlobeNewswire

Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

13 май 2024 08:00:00 Источник Nasdaq GlobeNewswire

Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results

08 май 2024 08:00:00 Источник Nasdaq GlobeNewswire

Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On Tinlarebant

06 май 2024 08:15:00 Источник Nasdaq GlobeNewswire

Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at the ARVO Annual Meeting

06 май 2024 08:00:00 Источник Nasdaq GlobeNewswire

Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting

01 май 2024 16:15:00 Источник Nasdaq GlobeNewswire

Belite Bio Announces $25 Million Registered Direct Offering

25 апр 2024 19:15:29 Источник Nasdaq GlobeNewswire

Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan

22 мар 2024 08:00:00 Источник Nasdaq GlobeNewswire

Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website

11 мар 2024 22:28:39 Источник Nasdaq GlobeNewswire

Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

11 мар 2024 21:27:47 Источник Nasdaq GlobeNewswire

Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results

06 мар 2024 08:00:01 Источник Nasdaq GlobeNewswire

Belite Bio to Participate in the Leerink Partners Global Biopharma Conference

04 мар 2024 08:00:00 Источник Nasdaq GlobeNewswire

Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

07 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire

Belite Bio to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference

30 ноя 2023 08:00:00 Источник Nasdaq GlobeNewswire

Belite Bio to Participate in the BTIG Ophthalmology Day

20 ноя 2023 08:00:00 Источник Nasdaq GlobeNewswire

Belite Bio Reports Third Quarter 2023 Operational Highlights and Financial Results

13 ноя 2023 20:15:47 Источник Nasdaq GlobeNewswire

Belite Bio to Host Webcast on November 14, 2023, to Discuss Third Quarter 2023 Financial Results

07 ноя 2023 08:00:00 Источник Nasdaq GlobeNewswire

Belite Bio Presents Results from a 24-month, Phase 2 Study of Tinlarebant in Childhood-onset Stargardt Disease at the AAO Annual Meeting

06 ноя 2023 08:00:00 Источник Nasdaq GlobeNewswire